Letizia C.
- Country
- Italy
- Department
- SOD di Endocrinologia
Research Overview
Data & Insights
Has run more than one trial at 6 of 37 partner sites.
Specializations
Endocrine & Metabolic Disorders
The investigator concentrates on hormone‑related and metabolic conditions affecting adult patients.
- type 1 diabetes
- type 2 diabetes
- obesity
- non-alcoholic steatohepatitis
- thyroid eye disease
Research includes evaluation of disease progression and therapeutic impact in diverse metabolic phenotypes.
Oncology & Solid Tumors
Broad clinical activity spans major solid malignancies with emphasis on targeted and immunologic strategies.
- breast cancer
- non-small cell lung cancer
- colorectal cancer
- renal cell carcinoma
- prostate cancer
- hepatocellular carcinoma
Investigations address molecular subtypes, resistance mechanisms, and combination regimens.
Hematologic Malignancies & Bone Marrow Disorders
Focused on malignant and clonal disorders of the hematopoietic system.
- acute myeloid leukemia
- myelodysplastic syndrome
- chronic lymphocytic leukemia
- multiple myeloma
- mantle cell lymphoma
Efforts include risk stratification and novel therapeutic sequencing.
Cardiovascular & Thrombotic Diseases
Clinical investigations target atherosclerotic and thrombo‑embolic pathologies.
- atherosclerotic cardiovascular disease
- atrial fibrillation
- acute myocardial infarction
- pulmonary embolism
- venous thromboembolism
Studies emphasize prevention, risk reduction, and long‑term outcomes.
Rare & Genetic Disorders
Engaged in clinical work on low‑prevalence inherited conditions.
- transthyretin amyloid cardiomyopathy
- fabry disease
- hereditary angioedema
- primary immune thrombocytopenia
- systemic sclerosis‑associated interstitial lung disease
Research integrates specialized diagnostics and disease‑modifying therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.